ClinicalTrials.Veeva

Menu
C

Coastal Research Institute | Fayetteville, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Glecaprevir
Firsocostat
BOS-580
Efimosfermin Alfa
Deudomperidone
CIN-102
Elafibranor
Ursodeoxycholic Acid
Cilofexor
Etrasimod

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 10 total trials

A Study of BOS-580 in Obese Subjects At Risk For, or with Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) with an Extension

This is a randomized, blinded, placebo-controlled study of Efimosfermin in obese participants at risk for, or with biopsy-confirmed, nonalcoholic ste...

Active, not recruiting
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: Efimosfermin

The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants wi...

Not yet enrolling
Metabolic Dysfunction-Associated Steatohepatitis
Drug: Efimosfermin
Drug: Placebo

The participants in this study will have confirmed PBC with inadequate response or intolerance to Ursodeoxycholic acid (UDCA), which is a medication...

Enrolling
Primary Biliary Cholangitis
Other: Placebo
Drug: Elafibranor

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastr...

Enrolling
Diabetic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 15mg or 10mg

Trial sponsors

Boston Scientific logo
Exact Sciences Corporation logo
AbbVie logo
C
Gilead Sciences logo
G
Ipsen logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems